JNJ-6204

CAS No. 2765264-50-2

JNJ-6204( —— )

Catalog No. M36281 CAS No. 2765264-50-2

JNJ-6204 is a dual inhibitor of CSNK1D (IC50 = 2.3 nM) and CSNK1E (IC50 = 137 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JNJ-6204
  • Note
    Research use only, not for human use.
  • Brief Description
    JNJ-6204 is a dual inhibitor of CSNK1D (IC50 = 2.3 nM) and CSNK1E (IC50 = 137 nM).
  • Description
    JNJ-6204 is a dual inhibitor of CSNK1D (IC50 = 2.3 nM) and CSNK1E (IC50 = 137 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    c-Fms
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2765264-50-2
  • Formula Weight
    370.41
  • Molecular Formula
    C19H11D6FN6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C1(C([2H])([2H])[2H])CN2C(=C(C(=N2)C3=CC=C(F)C=N3)C4=C5C(=NC=C4)NN=C5)CO1)([2H])([2H])[2H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mavrilimumab

    Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling.

  • c-Fms-IN-1

    c-Fms-IN-1 is an inhibitor of c-FMS kinase (IC50 = 0.8 nM).

  • c-FMS-IN-8

    c-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.